Conditions: Major Depressive Disorder
Keywords: Depressive Disorder Depression Depressive Disorder, Major Mood Disorders Mental Disorders Behavioural Symptoms
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 71
Healthy volunteers: no

Brief summary:
To evaluate the long-term safety and tolerability of flexible doses, 15 and 20 mg/day, of Vortioxetine over a period of 52 weeks in patients with Major Depressive Disorder (MDD)

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Vortioxetine (Lu AA21004)
Intervention descriptions: intervention 1: 15 or 20 mg/day; tablets; orally

Protocol document: